Pharmacy
Home Pharmacy
Most Cancer Drugs Approved in Europe Show No Survival Benefit
Even in the postmarketing period, half of cancers have no evidence of significant survival gain
WHO Suspends Testing of Hydroxychloroquine in COVID-19 Patients
In light of recent findings, hydroxychloroquine arm of WHO global study paused temporarily
Many College Students Believe Stimulants Can Boost Grades
More frequent use of alcohol, marijuana also tied to increased likelihood of prescription stimulant use
Arthritis Patients Needing to Shelter in Place Require More Support
Survey finds many experiencing increased symptoms, less physical activity, emotional issues
Pharmacist Education May Cut Junior Doctor Prescription Errors
Regular and targeted feedback by pharmacists reduces Rx errors; effect of e-learning tools unclear
Pay for Performance Cuts Mortality in Diabetes Patients
Program associated with lower risk for mortality, but not cancer incidence
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Gastric Acid Suppression May Promote Liver Injury
Expansion of intestinal Enterococcus faecalis in mice exacerbates ethanol-induced liver disease
Solanezumab Doesn’t Affect Cognitive Decline in Alzheimer’s
No difference between the drug and placebo in change in ADAS cognitive subscale score at week 80
Michigan Woman Gets Jail Time for Refusing to Vaccinate Son
Ruling is the latest round in a long-running custody fight